Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: A subgroup analysis of the CLUE trial

BMJ Open

Volumn 3, Issue 3, 2013, Pages

  Cannon, Chad M ^a   Levy, Phillip ^b,c   Baumann, Brigitte M ^d   Borczuk, Pierre ^e   Chandra, Abhinav ^f   Cline, David M ^g   Diercks, Deborah B ^h   Hiestand, Brian ^g,i   Hsu, Amy ^j   Jois, Preeti ^k   Kaminski, Brian ^l   Nowak, Richard M ^m   Schrock, Jon W ⁿ   Varon, Joseph ^o,p   Peacock, W Frank ^q  

^a UNIVERSITY OF KANSAS HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g WAKE FOREST SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ OHIO STATE UNIVERSITY   (United States)

^j LERNER RESEARCH INSTITUTE   (United States)

^k UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^l TOLEDO HOSPITAL   (United States)

^m HENRY FORD HOSPITAL   (United States)

ⁿ METROHEALTH MEDICAL CENTER   (United States)

^o UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^p UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^q BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LABETALOL; NICARDIPINE;

ADULT; ARTICLE; BLURRED VISION; CONFUSION; CONTINUOUS INFUSION; DIASTOLIC BLOOD PRESSURE; DIPLOPIA; DIZZINESS; DRUG EFFICACY; DYSPNEA; EMERGENCY WARD; FAINTNESS; FEMALE; HEART INFARCTION; HEART RATE; HEMATURIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SYMPTOM; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; UNCONSCIOUSNESS; UNITED STATES;

EID: 84876140064     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-002338     Document Type: Article

References (18)

1. Hajjar I, Kotchen T. Trends in prevalence, awareness,treatment, and control of hypertension in the United States, 1988-2000. JAMA2003;290:199-206. (Pubitemid 37430058)
2. Rodriguez MA, Kumar SK, De Caro M. Hypertensivecrisis. Cardiol Rev 2010;18:102-7.
3. Aggarwal M, Khan IA. Hypertensive crises:hypertensive emergencies and urgencies. Cardiol Clin 2006;24:135-46.
4. Marik PE, Varon J. Hypertensive crises: challenges andmanagement. Chest 2007;131:1949-62.
5. Deshmukh A, Kumar G, Kumar N, et al. Effect of JointNational Committee VII report on hospitalizations for hypertensive emergenciesin the United States.Am J Card 2011;108:1277-82.
6. Katz JN, Gore JM, Amin A, et al. Practice patterns,outcomes, and end-organ dysfunction for patients with acute severehypertension: the studying the treatment of acute hypertension (STAT) registry.Am Heart J 2009;158:599-606.
7. Wallin JD, Cook ME, Blanski L, et al. Intravenousnicardipine for the treatment of severe hypertension. Am J Med Sci1988;85:331-8.
8. Haas CE, LeBlanc JM. Acute postoperative hypertension: areview of therapeutic options. Am J Health Syst Pharm AJHP 2004;61:1661-73.
9. Peacock WF, Varon J, Baumann B, et al. CLUE: a randomizedcomparative effectiveness trial of IV nicardipine versus labetalol use in theemergency department. Crit Care 2011;15:R157.
10. Adams H, del Zoppo G, Alberts M, et al. Guidelines forthe early management of adults with ischemic stroke: a guideline from theAmerican Heart Association/American Stroke Association Stroke Council, ClinicalCardiology Council, Cardiovascular Radiology and Intervention Council, and theAtherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes inResearch Interdisciplinary Working Groups: the American Academy of Neurologyaffirms the value of this guideline as an educational tool for neurologists.Stroke 2007;38:1655-711.
11. Zampaglione B, Pascale C, Marchisio M, et al.Hypertensive urgencies and emergencies: prevalence and clinical presentation.Hypertension 1996;27:144-7. (Pubitemid 26017693)
12. Karras DJ, Kruus LK, Cienki JJ, et al. Evaluation andtreatment of patients with severely elevated blood pressure in academicemergency departments: a multicenter study. Ann Emerg Med 2006;47:230-6. (Pubitemid 43259508)
13. Karras DJ, Ufberg JW, Harrigan RA, et al. Lackofrelationship between hypertension-associated symptoms and blood pressure inhypertensive ED patients. Am J Emerg Med 2005;23:106-10. (Pubitemid 40349205)
14. Vaughan CJ, Delanty N: Hypertensive emergencies. Lancet2000;356:411-17. (Pubitemid 30487503)
15. Liu-DeRyke X, Parker D Jr, Levy P, et al. A prospectiveevaluation of labetalol vs nicardipine for blood pressure management inpatients with acute stroke. Crit Care Med 2009;37(Suppl):A161[Abstract No.342].
16. Liu-Deryke X, Janisse J, Coplin WM, et al. A comparisonof nicardipine and labetalol for acute hypertension management followingstroke. Neurocrit Care 2008;9:167-76.
17. Pollack C, Varon J, Garrison N, et al. Clevidipine, anintravenous dihydropyridine calcium channel blocker, is safe and effective forthe treatment of patients with acute severe hypertension. Ann Emerg Med2009;53:329-38.
18. Feldstein C. Management of hypertensive crises. Am JTher 2007;14:135-9. (Pubitemid 46597650)